Sample preparation of formalin-fixed paraffin-embedded tissue sections for MALDI-mass spectrometry imaging.

Formalin-fixed paraffin-embedded tissue sections MALDI imaging Optimized sample standard operating protocols (SOP) Tissue preparation

Journal

Analytical and bioanalytical chemistry
ISSN: 1618-2650
Titre abrégé: Anal Bioanal Chem
Pays: Germany
ID NLM: 101134327

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 06 10 2019
accepted: 20 11 2019
revised: 06 11 2019
pubmed: 29 1 2020
medline: 3 4 2020
entrez: 29 1 2020
Statut: ppublish

Résumé

Matrix-assisted laser desorption/ionization (MALDI) mass spectrometry imaging (MALDI MSI) has become a powerful tool with a high potential relevance for the analysis of biomolecules in tissue samples in the context of diseases like cancer and cardiovascular or cardiorenal diseases. In recent years, significant progress has been made in the technology of MALDI MSI. However, a more systematic optimization of sample preparation would likely achieve an increase in the molecular information derived from MALDI MSI. Therefore, we have employed a systematic approach to develop, establish and validate an optimized "standard operating protocol" (SOP) for sample preparation in MALDI MSI of formalin-fixed paraffin-embedded (FFPE) tissue sample analyses within this study. The optimized parameters regarding the impact on the resulting signal-to-noise (S/N) ratio were as follows: (i) trypsin concentration, solvents, deposition method, and incubation time; (ii) tissue washing procedures and drying processes; and (iii) spray flow rate, number of layers of trypsin deposition, and grid size. The protocol was evaluated on interday variability and its applicability for analyzing the mouse kidney, aorta, and heart FFPE tissue samples. In conclusion, an optimized SOP for MALDI MSI of FFPE tissue sections was developed to generate high sensitivity, to enhance spatial resolution and reproducibility, and to increase its applicability for various tissue types. This optimized SOP will further increase the molecular information content and intensify the use of MSI in future basic research and diagnostic applications. Graphical Abstract.

Identifiants

pubmed: 31989198
doi: 10.1007/s00216-019-02296-x
pii: 10.1007/s00216-019-02296-x
pmc: PMC7021751
doi:

Substances chimiques

Formaldehyde 1HG84L3525

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1263-1275

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : SFB-TRR219

Commentaires et corrections

Type : ErratumIn

Références

Open Neurol J. 2016 Sep 30;10:88-98
pubmed: 27843502
Sci Rep. 2017 Apr 4;7(1):603
pubmed: 28377615
Proteomics Clin Appl. 2015 Apr;9(3-4):335-41
pubmed: 25620724
Front Plant Sci. 2016 Feb 10;7:60
pubmed: 26904042
Mass Spectrom (Tokyo). 2014;3(Spec Issue):S0029
pubmed: 26819901
Biochim Biophys Acta Proteins Proteom. 2017 Jul;1865(7):784-794
pubmed: 27742553
Trends Biotechnol. 2011 Mar;29(3):136-43
pubmed: 21292337
J Vis Exp. 2014 Dec 05;(94):
pubmed: 25549242
Nat Protoc. 2016 Aug;11(8):1428-43
pubmed: 27414759
J Proteome Res. 2010 Sep 3;9(9):4315-28
pubmed: 20597554
Eur J Histochem. 2015 Nov 03;59(4):2532
pubmed: 26708177
Nanomaterials (Basel). 2017 Mar 21;7(3):
pubmed: 28336905
J Vis Exp. 2018 Jan 16;(131):
pubmed: 29364257
J Am Soc Mass Spectrom. 2010 Mar;21(3):338-47
pubmed: 19926301
Anal Chem. 2013 May 21;85(10):4998-5004
pubmed: 23594377
Mol Biosyst. 2017 Sep 26;13(10):1946-1953
pubmed: 28758666
Nat Protoc. 2011 Oct 13;6(11):1695-709
pubmed: 22011652
Biochim Biophys Acta Proteins Proteom. 2017 Jul;1865(7):837-845
pubmed: 27760391
Anal Bioanal Chem. 2011 Jul;401(1):65-73
pubmed: 21516518
J Proteomics. 2012 Aug 30;75(16):4893-4911
pubmed: 22554910
Proteomics. 2016 Jun;16(11-12):1670-7
pubmed: 27001204
Mol Biosyst. 2015 Jun;11(6):1507-14
pubmed: 25592401
Proteomics. 2016 Jun;16(11-12):1793-801
pubmed: 27061135
J Proteome Res. 2008 Aug;7(8):3543-55
pubmed: 18613713
J Neurosci Methods. 2016 Oct 15;272:19-32
pubmed: 26872743
Proteomics. 2014 Apr;14(7-8):956-64
pubmed: 24482424
Anal Bioanal Chem. 2015 Mar;407(8):2223-43
pubmed: 25687681
J Proteomics. 2014 Aug 28;108:465-8
pubmed: 24972319
J Am Soc Mass Spectrom. 2016 Jan;27(1):117-23
pubmed: 26384683
Histochem Cell Biol. 2015 May;143(5):453-62
pubmed: 25534592
Anal Bioanal Chem. 2015 Mar;407(8):2189-201
pubmed: 25424178
Proc Jpn Acad Ser B Phys Biol Sci. 2007 Nov;83(7):205-14
pubmed: 24367147
J Proteome Res. 2006 Nov;5(11):2889-900
pubmed: 17081040
Anal Chem. 2016 Jun 7;88(11):5988-95
pubmed: 27181709
Mass Spectrom Rev. 2016 Jan-Feb;35(1):147-69
pubmed: 25962625
Proteomics. 2008 Sep;8(18):3715-24
pubmed: 18712763
Metabolites. 2019 Jul 10;9(7):
pubmed: 31295847
Rapid Commun Mass Spectrom. 2015 Oct 15;29(19):1836-40
pubmed: 26331935
Anat Rec (Hoboken). 2010 May;293(5):821-8
pubmed: 20186963
Anal Chem. 2011 Jul 15;83(14):5728-34
pubmed: 21639088
Int J Mol Sci. 2010;11(12):5040-55
pubmed: 21614190
Sci Rep. 2016 Sep 21;6:33791
pubmed: 27650487
J Am Soc Mass Spectrom. 2017 Feb;28(2):376-383
pubmed: 27873216
Metallomics. 2017 Apr 19;9(4):365-381
pubmed: 28154861
Anal Chim Acta. 2017 Apr 15;962:52-59
pubmed: 28231880
Methods. 2016 Jul 15;104:93-100
pubmed: 26845462

Auteurs

Juliane Hermann (J)

Institute for Molecular Cardiovascular Research, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074, Aachen, Germany.

Heidi Noels (H)

Institute for Molecular Cardiovascular Research, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074, Aachen, Germany.

Wendy Theelen (W)

Institute for Molecular Cardiovascular Research, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074, Aachen, Germany.

Michaela Lellig (M)

Institute for Molecular Cardiovascular Research, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074, Aachen, Germany.

Setareh Orth-Alampour (S)

Institute for Molecular Cardiovascular Research, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074, Aachen, Germany.

Peter Boor (P)

Institute for Pathology, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074, Aachen, Germany.

Vera Jankowski (V)

Institute for Molecular Cardiovascular Research, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074, Aachen, Germany.

Joachim Jankowski (J)

Institute for Molecular Cardiovascular Research, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074, Aachen, Germany. jjankowski@ukaachen.de.
School for Cardiovascular Diseases, Maastricht University, Universiteitssingel 50, 6229 ER, Maastricht, The Netherlands. jjankowski@ukaachen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH